ENTITY
SMARTSCORE: 3/5

InflaRx NV (IFRX US)

3
Analysis
Health CareUnited States
InflaRx N.V. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies drugs for the treatment of inflammatory diseases. InflaRx serves patients worldwide.
more
03 Jun 2025 11:50Issuer-paid

Biopharma Week in Review - Possible Calm Before the Storm; Pharma Tariffs Looming

The holiday-shortened week was fairly quiet on the macro front, as certain vaccine-related actions by health agencies were largely expected.

Logo
198 Views
Share
No more insights
x